Stock IMCR IMMUNOCORE HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Immunocore Holdings plc

Equities

IMCR

US45258D1054

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
39.39 USD +3.58% Intraday chart for Immunocore Holdings plc +9.36% -42.34%
Jun. 18 Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment MT
Jun. 18 Immunocore Holdings plc Announces Randomization of First Patient in the Global, Registrational Phase 3 Clinical Trial Testing Brenetafusp for the Treatment of First-Line Advanced or Metastatic Cutaneous Melanoma CI

MarketScreener Strategies

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMCR Stock
  4. News Immunocore Holdings plc
  5. MarketScreener Strategies